251 related articles for article (PubMed ID: 21926097)
1. An investigation of side-effects and efficacy of foam-based sclerotherapy with carbon dioxide or room air in the treatment of reticular leg veins: a pilot study.
Peterson JD; Goldman MP
Phlebology; 2012 Mar; 27(2):73-6. PubMed ID: 21926097
[TBL] [Abstract][Full Text] [Related]
2. An investigation of coagulation cascade activation and induction of fibrinolysis using foam sclerotherapy of reticular veins.
Fabi SG; Peterson JD; Goldman MP; Guiha I
Dermatol Surg; 2012 Mar; 38(3):367-72. PubMed ID: 22092650
[TBL] [Abstract][Full Text] [Related]
3. Incidence of side effects using carbon dioxide-oxygen foam for chemical ablation of superficial veins of the lower extremity.
Morrison N; Neuhardt DL; Rogers CR; McEown J; Morrison T; Johnson E; Salles-Cunha SX
Eur J Vasc Endovasc Surg; 2010 Sep; 40(3):407-13. PubMed ID: 20547080
[TBL] [Abstract][Full Text] [Related]
4. Air versus physiological gas for ultrasound guided foam sclerotherapy treatment of varicose veins.
Beckitt T; Elstone A; Ashley S
Eur J Vasc Endovasc Surg; 2011 Jul; 42(1):115-9. PubMed ID: 21531588
[TBL] [Abstract][Full Text] [Related]
5. Preliminary experience with a new sclerosing foam in the treatment of varicose veins.
Tessari L; Cavezzi A; Frullini A
Dermatol Surg; 2001 Jan; 27(1):58-60. PubMed ID: 11231246
[TBL] [Abstract][Full Text] [Related]
6. Neurological and chest symptoms following sclerotherapy: a single centre experience.
Hill DA
Phlebology; 2014 Oct; 29(9):619-27. PubMed ID: 23945346
[TBL] [Abstract][Full Text] [Related]
7. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review.
Willenberg T; Smith PC; Shepherd A; Davies AH
Phlebology; 2013 Apr; 28(3):123-31. PubMed ID: 23761921
[TBL] [Abstract][Full Text] [Related]
8. Foam sclerotherapy for reticular veins and nontruncal varicose veins of the legs: a retrospective review of outcomes and adverse effects.
Palm MD; Guiha IC; Goldman MP
Dermatol Surg; 2010 Jun; 36 Suppl 2():1026-33. PubMed ID: 20590709
[TBL] [Abstract][Full Text] [Related]
9. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
Uncu H
Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
[TBL] [Abstract][Full Text] [Related]
10. Media Damage Following Detergent Sclerotherapy Appears to be Secondary to the Induction of Inflammation and Apoptosis: An Immunohistochemical Study Elucidating Previous Histological Observations.
Whiteley MS; Dos Santos SJ; Fernandez-Hart TJ; Lee CT; Li JM
Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):421-8. PubMed ID: 26790396
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of ultrasound-guided foam sclerotherapy for recurrent varicose veins: immediate results.
Kakkos SK; Bountouroglou DG; Azzam M; Kalodiki E; Daskalopoulos M; Geroulakos G
J Endovasc Ther; 2006 Jun; 13(3):357-64. PubMed ID: 16784324
[TBL] [Abstract][Full Text] [Related]
12. Venous gas embolism during foam sclerotherapy of saphenous veins despite recommended treatment modifications.
Parsi K
Phlebology; 2011 Jun; 26(4):140-7. PubMed ID: 21087951
[TBL] [Abstract][Full Text] [Related]
13. Complications and side-effects of foam sclerotherapy.
Guex JJ
Phlebology; 2009 Dec; 24(6):270-4. PubMed ID: 19952383
[TBL] [Abstract][Full Text] [Related]
14. European guidelines for sclerotherapy in chronic venous disorders.
Rabe E; Breu FX; Cavezzi A; Coleridge Smith P; Frullini A; Gillet JL; Guex JJ; Hamel-Desnos C; Kern P; Partsch B; Ramelet AA; Tessari L; Pannier F;
Phlebology; 2014 Jul; 29(6):338-54. PubMed ID: 23559590
[TBL] [Abstract][Full Text] [Related]
15. Sclerotherapy and foam sclerotherapy for varicose veins.
Coleridge Smith P
Phlebology; 2009 Dec; 24(6):260-9. PubMed ID: 19952382
[TBL] [Abstract][Full Text] [Related]
16. Infusion of foam sclerosants results in a distance-dependent procoagulant activity, haemoconcentration and elevation of D-dimer levels.
Connor DE; Joseph JE; Exner T; Ma DD; Parsi K
Phlebology; 2014 Dec; 29(10):677-87. PubMed ID: 24002013
[TBL] [Abstract][Full Text] [Related]
17. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study).
Rabe E; Schliephake D; Otto J; Breu FX; Pannier F
Phlebology; 2010 Jun; 25(3):124-31. PubMed ID: 20483861
[TBL] [Abstract][Full Text] [Related]
18. An investigation on the influence of glycerin on sclerosant foam stability.
Peterson JD; Goldman MP
Phlebology; 2011 Sep; 26(6):232-4. PubMed ID: 21415429
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation.
Morrison N; Neuhardt DL; Rogers CR; McEown J; Morrison T; Johnson E; Salles-Cunha SX
J Vasc Surg; 2008 Apr; 47(4):830-6. PubMed ID: 18242937
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.
Bush R; Bush P
Phlebology; 2017 Aug; 32(7):496-500. PubMed ID: 27738241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
